46
G. Albertin et al. / Journal of Organometallic Chemistry 702 (2012) 45e51
CDM 83. Elemental analyses were determined in the Microanalyt-
ical Laboratory of the Dipartimento di Scienze Farmaceutiche,
University of Padova (Italy).
1c: 1H NMR (CD2Cl2, 25 ꢁC)
d: 7.85e6.86 (m, 25 H, Ph), ABCDX, dA
5.52, dB 5.62, dC 5.07, dD 5.66, JAB ¼ 5.9, JAC ¼ 0.6, JAD ¼ 1.0, JAx ¼ 0.6,
JBC ¼ 1.0, JBD ¼ 0.6, JBx ¼ 1.7, JCD ¼ 5.9, JCx ¼ 1.6, JDx ¼ 1.5 (4 H, Ph p-
cym), EFGHX spin syst (X ¼ 31P), dE
¼
dG 4.24, dF
¼
dH 3.11,
JEG ¼ JFH ¼ 9.5, JEH ¼ JFG ¼ 9.2, JEF ¼ JGH ¼ 0.6, JEx ¼ JGx ¼ 3.8,
JFx ¼ JHx ¼ 2.1 (4 H, CH2 ethylene), 4.04 (m, 4 H, CH2 phos), 2.28 (m,
1 H, CH iPr), 1.68 (s, 3 H, CH3 p-cym), 1.39 (JHH ¼ 7.0), 1.33 (JHH ¼ 7.0)
(t, 6 H, CH3 phos), 1.09 (JHH ¼ 6.7), 1.07 (JHH ¼ 6.6) (d, 6 H, CH3 iPr).
2.2. Synthesis of complexes
Complexes [OsCl(
m
-Cl)(
h
6-p-cymene)]2, OsCl2(
h
6-p-cymene)L
[L ¼ P(OMe)3, P(OEt)3, PPh(OEt)2] and OsCl2(
h
6-p-cymene)(CNR)
31P{1H} NMR (CD2Cl2, 25 ꢁC) : 84.2 (s). 13C{1H} NMR (CD2Cl2, 25 ꢁC)
d
(R ¼ tBu, p-tolyl) were prepared following the methods previously
d
: 165e122 (m, Ph), 116.24 (d, JCP ¼ 1.8, C1 p-cym), 104.06 (s, C4),
reported [9d,13].
91.65 (d, JCP ¼ 2.3, C5), 90.37 (d, JCP ¼ 3.7, C3), 86.57 (d, JCP ¼ 5.8, C6),
81.22 (d, JCP ¼ 5.2, C2), 66.96, 66.93, 66.26 (d, JCP ¼ 11.0, CH2 phos),
i
6-p-cymene)(
h
2-CH2]CH2)L]BPh4 (1) [P ¼ P(OMe)3 (a),
51.00 (d, JCP ¼ 1.5, CH2 ethylene), 30.74 (s, CH Pr), 21.95, 21.50 (s,
2.3. [OsCl(
P(OEt)3 (b), PPh(OEt)2 (c)]
h
CH3 iPr), 17.31 (s, CH3 p-cym), 16.31 (JCP ¼ 6.7), 16.22 (JCP ¼ 6.6) (d,
CH3 phos). LM ¼ 53.5
U
ꢀ1 molꢀ1 cm2. C46H53BClO2OsP (905.38): C
61.02, H 5.90, Cl, 3.92; found C 59.84, H 6.02, Cl 3.70%.
In a 25-mL three-necked round-bottomed flask were placed
a solid sample of the appropriate complex OsCl2(
6-p-cymene)L
h
2.4. [OsCl(
h
6-p-cymene)( 2-CH2]CH2)(CNtBu)]BPh4 (2)
h
(0.38 mmol), an excess of NaBPh4 (0.77 mmol, 0.26 g), and 4 mL of
ethanol. The resulting mixture was stirred under an ethylene
atmosphere (1 atm) at room temperature for 24 h. The yellow solid
which separated out was filtered and crystallized under ethylene
from CH2Cl2 and ethanol; yield ꢂ90%.
In a 25-mL three-necked round-bottomed flask were placed
0.20 g (0.41 mmol) of OsCl2(
6-p-cymene)(CNtBu), an excess of
h
NaBPh4 (0.82 mmol, 0.28 g) and 4 mL of ethanol. The resulting
mixture was stirred under an ethylene atmosphere (1 atm) at room
temperature for 30 h. A yellow solid separated out which was
filtered and crystallized under ethylene from CH2Cl2 and ethanol;
1a: 1H NMR (CD2Cl2, 25 ꢁC)
d (see Chart 1): 7.40e6.87 (m, 20 H,
BPh4), ABCDX spin syst (X ¼ 31P), dA 5.77, dB 5.21, dC 5.87, dD 5.73,
JAB ¼ 6.2, JAC ¼ 0.8, JAD ¼ 1.2, JAx ¼ 0.1, JBC ¼ 1.2, JBD ¼ 0.8, JBx ¼ 1.0,
JCD ¼ 6.2, JCx ¼ 1.6, JDx ¼ 1.2 (4 H, Ph p-cym), EFGHX spin syst
yield ꢂ80%. IR (KBr) nCN: 2191 (s) cmꢀ1. 1H NMR (CD2Cl2, ꢀ30 ꢁC)
d:
(X ¼ 31P), dE
¼
dG 4.15, dF
¼ dH 3.15, JEG ¼ JFH ¼ 9.7, JEH ¼ JFG ¼ 9.0,
7.85e6.86 (m, 20 H, BPh4), ABCD, dA 5.05, dB 5.15, dC 5.49, dD 5.09,
JAB ¼ 6.0, JAC ¼ 0.7, JAD ¼ 1.2, JBC ¼ 1.2, JBD ¼ 0.7, JCD ¼ 6.0 (4 H, Ph p-
JEF ¼ JGH ¼ 0.6, JEx ¼ JGx ¼ 4.4, JFx ¼ JHx ¼ 1.9 Hz (4 H, CH2 ethylene),
cym), EFGH spin syst (X ¼ 31P), dE
¼
dG 4.04, dF
¼
dH 3.47,
i
3.87 (d, 9 H, JHP ¼ 11.0, CH3 phos), 2.43 (m, 1 H, JHH ¼ 6.9, CH Pr),
1.20 (d, 3 H, JHH ¼ 7.0, CH3 p-cym), 1.15 (d, 6 H, JHH ¼ 6.9, CH3 iPr)
JEG ¼ JFH ¼ 17.6, JEH ¼ JFG ¼ 9.6, JEF ¼ JGH ¼ 0.6 (4 H, CH2 ethylene),
2.41 (m, 1 H, CH iPr), 1.54 (s, 9 H, CH3 tBu), 1.31 (s, 3 H, CH3 p-cym),
1.15 (JHH ¼ 6.9), 1.14 (JHH ¼ 6.8) (d, 6 H, CH3 iPr). 13C{1H} NMR
ppm. 31P{1H} NMR (CD2Cl2, 25 ꢁC) : 60.4 (s). 13C{1H} NMR (CD2Cl2,
d
25 ꢁC)
d
: 165e122 (m, BPh4), 116.96 (d, JCP ¼ 2.8, C1 p-cym), 106.24
(CD2Cl2, 25 ꢁC)
d: 165e122 (m, BPh4), 111.24 (s, C1 p-cym), 105.73 (s,
(d, JCP ¼ 1.0, C4), 91.30 (d, JCP ¼ 4.2, C5), 90.01 (d, JCP ¼ 2.1, C3), 88.61
(d, JCP ¼ 1.3, C6), 88.11 (d, JCP ¼ 3.0, C2), 56.77 (d, JCP ¼ 9.5, CH3
C4), 89.39 (s, C5), 88.47 (s, C3), 88.24 (s, C6), 86.32 (s, C2), 60.17 (s,
C]N), 57.91 (s, CH2 ethylene), 31.56 (s, CH iPr), 31.23 (s, CMe3 tBu),
30.29 (s, CH3 tBu), 22.00, 21.91 (s, CH3 iPr), 18.08 (s, CH3 p-cym).
i
phos), 50.02 (d, JCP ¼ 3.6, CH2 ethylene), 31.07 (s, CH Pr), 22.02,
21.67 (s, CH3 iPr), 17.98 (s, CH3 p-cym). LM ¼ 56.2 Uꢀ1 molꢀ1 cm2.
C39H47BClO3OsP (831.26): C 56.35, H, 5.70, Cl 4.26; found C 56.11, H
5.81, Cl 4.08%.
LM ¼ 55.1
U
ꢀ1 molꢀ1 cm2. C41H47BClNOs (790.31): C 62.31, H 5.99,
N 1.77, Cl 4.49; found C 62.13, H 6.10, N 1.68, Cl 4.71%.
1b: 1H NMR (CD2Cl2, 25 ꢁC)
d: 7.35e6.90 (m, 20 H, BPh4), ABCDX,
2.5. [OsCl(p-tolyl-NH2)(
h
6-p-cymene){PPh(OEt)2}]BPh4 (3) and
6-p-cymene)(CH3NHNH2){PPh(OEt)2}]BPh4 (4)
dA 5.77, dB 5.18, dC 5.87, dD 5.69, JAB ¼ 6.0, JAC ¼ 0.5, JAD ¼ 1.3, JAx ¼ 0.7,
[OsCl(
h
JBC ¼ 1.3, JBD ¼ 0.5, JBx ¼ 0.4, JCD ¼ 6.0, JCx ¼ 0.8, JDx ¼ 0.3 (4 H, Ph p-
cym), EFGHX spin syst (X ¼ 31P), dE
¼
dG 4.15, dF
¼
dH 3.14,
To a solution of [OsCl(
h
6-p-cymene)( 2-CH2]CH2){PPh(OEt)2}]
h
JEG ¼ JFH ¼ 11.2, JEH ¼ JFG ¼ 9.1, JEF ¼ JGH ¼ 0.6, JEx ¼ JGx ¼ 4.4,
JFx ¼ JHx ¼ 1.9 (m, 4 H, CH2 ethylene), 4.06 (m, 6 H, CH2 phos), 2.46
BPh4 (100 mg, 0.11 mmol) in CH2Cl2 (10 mL) was added an excess of
p-toluidine (0.33 mmol, 35 mg), in one case, or an excess of
i
(m, 1 H, JHH ¼ 7.0, CH Pr), 1.90 (s, 3 H, CH3 p-cym), 1.33 (td, 9 H,
methylhydrazine (0.33 mmol, 18
mL) in the other. The reaction
JHH ¼ 7.0, JHH ¼ 0.46, CH3 phos), 1.20 (JHH ¼ 6.9), 1.17 (JHH ¼ 6.9) (d,
6 H, CH3 iPr). 31P{1H} NMR (CD2Cl2, 25 ꢁC) : 55.49 (s). 13C{1H} NMR
d
mixture was stirred at room temperature for 2 h. The solvent was
removed under reduced pressure to give an oil, which was treated
with ethanol (3 mL) containing an excess of NaBPh4 (0.22 mmol,
75 mg). A yellow solid slowly separated out, which was filtered and
crystallised from CH2Cl2 and ethanol; yield ꢂ80%.
(CD2Cl2, 25 ꢁC)
d
: 165-122 (m, BPh4), 117.13 (d, JCP ¼ 2.8, C1 p-cym),
105.32 (s, C4), 91.46 (d, JCP ¼ 4.2, C5), 90.48 (d, JCP ¼ 2.2, C3), 88.55
(d, JCP ¼ 1.3, C6), 88.06 (d, JCP ¼ 6.7, C2), 66.14 (d, JCP ¼ 9.9, CH2
i
phos), 49.77 (d, JCP ¼ 3.4, CH2 ethylene), 30.98 (s, CH Pr), 21.96,
3: LM ¼ 52.8 Uꢀ1 molꢀ1 cm2. C51H58BClNO2OsP (984.48): C
62.22, H 5.94, N 1.42, Cl 3.60; found C 62.08, H 6.08, N 1.55, Cl 3.42%.
4: LM ¼ 54.1 Uꢀ1 molꢀ1 cm2. C45H55BClN2O2OsP (923.40): C
58.53, H 6.00, N 3.03, Cl 3.84; found C 58.71, H 5.87, N 3.15, Cl 3.64%.
IR and NMR data were exactly the same of the related complexes
previously prepared [9d,30].
21.69 (s, CH3 iPr), 17.82 (s, CH3 p-cym), 16.29 (d, JCP ¼ 6.4, CH3 phos).
LM ¼ 52.8 Uꢀ1 molꢀ1 cm2. C42H53BClO3OsP (873.34): C 57.76, H
6.12, Cl 4.06; found C 57.55, H 6.02, Cl 4.29%.
HB
C4
HA
C1
HE
HF
C3
C5
C2
C6
CH3
H
C
C
2.6. [OsCl{]C]C(H)Ph}(h
6-p-cymene){PPh(OEt)2}]þCF3SOꢀ3 (5)
H3C
C
[Os]
CH3
An excess of phenylacetylene (0.33 mmol, 37
mL) was added to
a solution of [OsCl(
h
6-p-cymene)( 2-CH2]CH2){PPh(OEt)2}]BPh4
h
HH
HG
HC
HD
(100 mg, 0.11 mmol) in CH2Cl2 (7 mL) and the reaction mixture was
stirred at room temperature for 3 h. The solvent was removed
under reduced pressure to give an oil, which was characterised as
Chart 1. Labeling scheme of the p-cymene and ethylene ligands used for the NMR
study.